| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615988 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 33 Pages |
Abstract
The use of the IPSS-R and WPSS systems simultaneously might help in identifying those patients who require more aggressive treatment. Nevertheless, more efforts are needed to improve the identification of those lower risk patients whose survival is significantly reduced by progression to AML.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Alicia Enrico, Yesica Bestach, Maria Gabriela Flores, Jorge Arbelbide, Camila Serale, Viviana Novoa, Renée Crisp, MarÃa Marta Rivas, Irene Larripa, Carolina Belli,